EVIO, Inc. (EVIO)

Our latest clients all have the potential to grow significantly in the near and long-term future

EVIO, Inc. (EVIO)

Postby QualityStocks » Thu Oct 05, 2017 10:30 pm

EVIO, Inc., via the EVIO Labs division, is the nation's leading provider of accredited analytical testing, scientific research and advisory services to the regulated cannabis industry. EVIO Labs provides state-mandated ancillary services that are required to ensure the safety and quality of the nation's cannabis supply. EVIO Labs has performed over 50,000 tests during the past two years and grown from one laboratory in Oregon to nine labs spanning California, Oregon, Colorado, Massachusetts and Florida.

EVIO Labs is driving the cannabis testing industry by providing clients nationwide with consistent high-quality cannabis analytical services backed by quality control assurances. The company also provides advisory services that help cannabis producers and retailers enhance production processes, achieve regulatory compliance and meet quality goals.

EVIO Labs is on track to open 18 laboratories by the end of 2018 at locations around the United States. The Oregon-based company provides analytical services that include testing cannabis and industrial hemp flower, extracts and infused products. The labs specialize in performing the following tests:

- Cannabinoid analysis, which properly characterizes the many primary cannabinoids found in cannabis including THC, CBD, and several other cannabinoids.
- Terpene analysis, which identifies the aromatic compounds of the plant (terpene), which can help identify the therapeutic potential of a cannabis flower or extract.
- Moisture content and water activity, which measure the moisture levels of dried cannabis and are indicators of microbiological growth potential.
- Pesticide residue analysis of over 100 different pesticides, herbicides, fungicides, growth regulators and other agrochemicals that may be present on cannabis.
- Detection of harmful residual solvents left behind in the cannabis extract production process.
- Microbial testing screen for bacterial and fungal contamination in cannabis and cannabis-infused products.
- Detection of heavy metals including lead, cadmium, mercury, and arsenic.

EVIO Labs is rapidly becoming the nation's leading cannabis biotechnology company. Led by a management team with extensive experience in designing and rolling out successful business ventures, product research and development, regulatory and compliance protocols, medical cannabis cultivation, production and analytical chemistry techniques, EVIO Labs is prepared to take advantage of today's fastest growing industry.
The QualityStocks Daily Newsletter http://Newsletter.QualityStocks.net

The QualityStocks Daily Blogs http://Blog.QualityStocks.net

Please read FULL Compensation Disclosures and other disclaimers at http://www.qualitystocks.net/disclaimer.php
QualityStocks
Site Admin
 
Posts: 1506
Joined: Mon May 21, 2007 7:58 pm
Location: Scottsdale, AZ

Re: EVIO, Inc. (EVIO)

Postby QualityStocks » Fri Oct 06, 2017 3:55 pm

EVIO, Inc. (EVIO) is “One to Watch”

- Rapidly expanding network of analytical cannabis testing laboratories now serving five states
- Accurate, reliable lab results based on scientific principles using state-of-the-art facilities
- Analytical services include testing cannabis flowers, extracts and infused products

EVIO, Inc. (OTCQB: EVIO), via the EVIO Labs division, is the nation’s leading provider of accredited analytical testing, scientific research and advisory services to the regulated cannabis industry. EVIO Labs provides state-mandated ancillary services that are required to ensure the safety and quality of the nation’s cannabis supply. EVIO Labs has performed over 50,000 tests during the past two years and grown from one laboratory in Oregon to nine labs spanning California, Oregon, Colorado, Massachusetts and Florida.

EVIO Labs is driving the cannabis testing industry by providing clients nationwide with consistent high-quality cannabis analytical services backed by quality control assurances. The company also provides advisory services that help cannabis producers and retailers enhance production processes, achieve regulatory compliance and meet quality goals.

EVIO Labs is on track to open 18 laboratories by the end of 2018 at locations around the United States. The Oregon-based company provides analytical services that include testing cannabis and industrial hemp flower, extracts and infused products. The labs specialize in performing the following tests:

Cannabinoid analysis, which properly characterizes the many primary cannabinoids found in cannabis including THC, CBD, and several other cannabinoids.
Terpene analysis, which identifies the aromatic compounds of the plant (terpene), which can help identify the therapeutic potential of a cannabis flower or extract.
Moisture content and water activity, which measure the moisture levels of dried cannabis and are indicators of microbiological growth potential.
Pesticide residue analysis of over 100 different pesticides, herbicides, fungicides, growth regulators and other agrochemicals that may be present on cannabis.
Detection of harmful residual solvents left behind in the cannabis extract production process.
Microbial testing screen for bacterial and fungal contamination in cannabis and cannabis-infused products.
Detection of heavy metals including lead, cadmium, mercury, and arsenic.
EVIO Labs is rapidly becoming the nation’s leading cannabis biotechnology company. Led by a management team with extensive experience in designing and rolling out successful business ventures, product research and development, regulatory and compliance protocols, medical cannabis cultivation, production and analytical chemistry techniques, EVIO Labs is prepared to take advantage of today’s fastest growing industry.

For more information, visit the company’s website at www.EVIOLabs.com
The QualityStocks Daily Newsletter http://Newsletter.QualityStocks.net

The QualityStocks Daily Blogs http://Blog.QualityStocks.net

Please read FULL Compensation Disclosures and other disclaimers at http://www.qualitystocks.net/disclaimer.php
QualityStocks
Site Admin
 
Posts: 1506
Joined: Mon May 21, 2007 7:58 pm
Location: Scottsdale, AZ

Re: EVIO, Inc. (EVIO)

Postby QualityStocks » Thu Oct 12, 2017 6:02 pm

NetworkNewsBreaks – Why Cannabis Market Investors are Keeping an Eye on EVIO, Inc. (EVIO)

EVIO, Inc. (OTCQB: EVIO), through its EVIO Labs division, is a national leader in providing accredited analytical testing, scientific research and advisory services to the regulated cannabis industry and provides state-mandated ancillary services required for ensuring the safety and quality of the cannabis supply in the United States. During the past two years, EVIO Labs has performed more than 50,000 tests and has evolved from operating one laboratory in Oregon to having nine labs that span California, Oregon, Colorado, Massachusetts and Florida. An article discussing this reads: “EVIO Labs is driving the cannabis testing industry by providing clients nationwide with consistent high-quality cannabis analytical services backed by quality control assurances. The company also provides advisory services that help cannabis producers and retailers enhance production processes, achieve regulatory compliance and meet quality goals. EVIO Labs is on track to open 18 laboratories by the end of 2018 at locations around the United States. The Oregon-based company provides analytical services that include testing cannabis and industrial hemp flower, extracts and infused products.”
The QualityStocks Daily Newsletter http://Newsletter.QualityStocks.net

The QualityStocks Daily Blogs http://Blog.QualityStocks.net

Please read FULL Compensation Disclosures and other disclaimers at http://www.qualitystocks.net/disclaimer.php
QualityStocks
Site Admin
 
Posts: 1506
Joined: Mon May 21, 2007 7:58 pm
Location: Scottsdale, AZ

Re: EVIO, Inc. (EVIO)

Postby QualityStocks » Wed Oct 18, 2017 6:10 pm

EVIO, Inc. (EVIO) Prepares for New Cannabis Testing Rules in California Ahead of January Recreational Legalization

- EVIO maintains cannabis labs in five states, and it plans to have 18 labs by the end of 2018 that provide testing to ensure the quality and safety of the cannabis supply
- The company’s goal is to become the industry’s largest cannabis testing company, says CEO
- Serving the legalized cannabis industry, EVIO sees California becoming the biggest marketplace globally. Estimates are that the cannabis market there could reach $4-$7 billion annually

EVIO, Inc. (OTCQB: EVIO) is readying itself for new testing rules in California, which it foresees as the largest cannabis marketplace in the world (http://nnw.fm/aUT1Y). Its labs in that state will analyze newly legalized recreational marijuana in January 2018. Its Yuba City, California lab is already testing cannabis under current rules, but they are expecting all new and more stringent requirements come January.

EVIO already has labs in five states and is planning to have 18 by the end of 2018. The publicly-traded Oregon-based company now has labs in Massachusetts, Florida, Oregon, Colorado, and California. EVIO serves the cannabis industry by testing for pesticides, solvents, micro-biological contaminants, heavy metals, and cannabinoids. It also provides the industry with advisory services including in the areas of compliance and product development.

EVIO is a life sciences company which provides the regulated cannabis industry with accredited analytical testing services. Part of its growth comes from license agreements, offering the EVIO brand to other labs. EVIO’s goal is to become the largest cannabis testing company in the industry, said William Waldrop, CEO and founder of the company (http://nnw.fm/h6gOo).

It anticipates that new testing rules for California will be announced before January, but based on draft rules already published, requirements are for testing for 66 pesticides, 22 solvents, and heavy metals. The metals include lead, arsenic, mercury, and cadmium. The proposed California analysis requirements will be similar to how EVIO is already testing in Oregon.

EVIO foresees that new testing rules for pesticides will be announced in November 2017. It also expects a high early failure rate on the cannabis it tests — the same pattern it saw in its home state of Oregon. It experienced a 25% failure rate in extracts and concentrates when the new rules were first introduced. But testing approvals increased later in the first year as growers quickly addressed the issues.

The new more stringent tests are important because EVIO sees California as not only a vibrant opportunity, but eventually the biggest cannabis marketplace in the world. Regimented regulatory oversight is to be expected, including lab testing, the company said. According to the San Diego Union-Tribune (http://nnw.fm/6cpwY), California’s cannabis industry could be worth from $4-$7 billion.

For more information, visit the company’s website at www.EVIOLabs.com
The QualityStocks Daily Newsletter http://Newsletter.QualityStocks.net

The QualityStocks Daily Blogs http://Blog.QualityStocks.net

Please read FULL Compensation Disclosures and other disclaimers at http://www.qualitystocks.net/disclaimer.php
QualityStocks
Site Admin
 
Posts: 1506
Joined: Mon May 21, 2007 7:58 pm
Location: Scottsdale, AZ

Re: EVIO, Inc. (EVIO)

Postby QualityStocks » Wed Oct 18, 2017 6:20 pm

NetworkNewsBreaks – EVIO, Inc. (EVIO) Announces Strong Start to Fiscal 2018

EVIO, Inc. (OTCQB: EVIO), a leading provider of cannabis analytical testing services, this morning announced that its EVIO Labs division has already exceeded last October’s testing revenues through the first half of October 2017, with sales surpassing $250,000. “Our national sales team continues to expand EVIO’s service offerings,” William Waldrop, CEO of EVIO, stated in the news release. “After an impressive 2017, in which we exceeded our own internal projections, we are starting the 2018 fiscal year on the right track. We are eagerly waiting for the upcoming accreditation of our new pesticide equipment. As mentioned in our 8K, the Oregon Environmental Laboratory Accreditation Program (ORELAP) has provided Monday, October 23, 2017 as their on-site assessment date. As soon [as] our accreditation scope is expanded to include full-service pesticides, the company will be able to perform a majority of our testing in-house. This will tremendously improve our gross margins and overall profitability.”
The QualityStocks Daily Newsletter http://Newsletter.QualityStocks.net

The QualityStocks Daily Blogs http://Blog.QualityStocks.net

Please read FULL Compensation Disclosures and other disclaimers at http://www.qualitystocks.net/disclaimer.php
QualityStocks
Site Admin
 
Posts: 1506
Joined: Mon May 21, 2007 7:58 pm
Location: Scottsdale, AZ

Re: EVIO, Inc. (EVIO)

Postby QualityStocks » Wed Oct 25, 2017 3:37 am

NetworkNewsBreaks – EVIO, Inc. (EVIO) Opens Fifth Testing Location in Eastern Oregon

EVIO, Inc. (OTCQB: EVIO), a leading provider of cannabis analytical testing services, this morning announced the opening of its fifth testing location in eastern Oregon. “We are excited to announce our new location in La Grande, OR,” William Waldrop, CEO of EVIO, stated in the news release. “Oregon recently passed OAR 603-048 which requires all industrial hemp and hemp derived manufactured products to be tested by an accredited testing lab prior to being made available for sale. Our new location, is the only lab in eastern Oregon and is strategically located near a significant number of Oregon’s 233 licensed hemp growers and 173 licensed manufacturers and distributors… We feel these new rules can add an additional 40% to the potential Oregon testing market in the short term and products derived by CBD can eventually outpace the existing medical and recreational cannabis markets.”
The QualityStocks Daily Newsletter http://Newsletter.QualityStocks.net

The QualityStocks Daily Blogs http://Blog.QualityStocks.net

Please read FULL Compensation Disclosures and other disclaimers at http://www.qualitystocks.net/disclaimer.php
QualityStocks
Site Admin
 
Posts: 1506
Joined: Mon May 21, 2007 7:58 pm
Location: Scottsdale, AZ

Re: EVIO, Inc. (EVIO)

Postby QualityStocks » Sat Oct 28, 2017 7:28 am

Oregon Overhauls its Approach to Industrial Hemp

Passage of a new law in Oregon that requires industrial hemp growers to register with the state is seen as a positive move for the industry, advocates of the program are saying.

Signed by Oregon Gov. Kate Brown and overwhelmingly passed by members of the Oregon Legislature, Senate Bill 1015 (http://nnw.fm/BuQ9o) went into effect on Oct. 6, 2017. The measure gives the Oregon Liquor Control Commission (OLCC) authority over the processing of industrial hemp and requires those who grow or process the plant to register and pay a fee. Licensed recreational marijuana producers and dispensaries would also have to register with the OLCC before selling hemp products (http://nnw.fm/g9He5). The new law expands some plant testing and record-keeping requirements for both the industrial hemp grower and processor.

“Hemp is growing in popularity and value with farmers throughout the state,” said Tom Burns of Chalice Farms in his testimony supporting the new legislation (http://nnw.fm/V1dzb). “Unfortunately, the processing (making into usable products) of hemp is lagging behind the desire of farmers to grow the product.”

Under the new law, registered industrial hemp growers can deliver their harvest to a licensed marijuana processor where it can be made into concentrates and extracts. Hemp is defined as having less than 3 percent THC (tetrahydrocannabinol), the psychoactive chemical in cannabis. When it comes to CBD concentrates and extracts, the bill would open up industrial hemp processing to state licensed recreational marijuana processers. The processed CBD concentrates and extracts could then be delivered to recreational marijuana retailers for sale in licensed dispensaries or be delivered back to a registered industrial hemp handler for resale, according to the Canna Law Group, which provides legal support for the cannabis business community (http://nnw.fm/982vB).

Eric Shoemaker of Swell Companies Ltd. voiced his support for the law as well, saying the bill was a “vital step forward for Oregon.”

“We have continued to be surprised that greater efforts have not been made to integrate industrial hemp into the OLCC system,” Shoemaker testified (http://nnw.fm/eVKz8). “We believe industrial hemp will be a more significant industry for Oregon (and the nation) than recreational cannabis.”

The Oregon Department of Agriculture handles the registration aspect of the new law, which requires industrial hemp growers and handlers (processors) to each pay a $1,300 fee in addition to a $120 agricultural hemp seed production fee. The legislation requires growers to provide testing results to the recreational processor with that information retained and made available to the state.

Several testing companies are already accredited to conduct the required tests. EVIO, Inc. (OTCQB: EVIO), through its EVIO Labs division, was primed and ready to offer accredited analytical testing services to Oregon’s industrial hemp sector the moment the law came into effect.

“Industrial hemp is a rapidly growing industry with product applications ranging from foods like hemp seed, personal care products, textiles, and other industrial and consumer goods such as building materials,” says EVIO Inc.’s COO Lori Glauser, pointing out hemp-based CBD oil sales are projected to reach $1 billion by 2020 (http://nnw.fm/s0eHM).

Oregon currently has 233 actively licensed industrial hemp growers and each is required by the state to complete testing prior to harvest to ensure their hemp is qualified for sale. While restrictions are built into Oregon’s legislation, advocates are quick to point out it also opens up new possibilities for the lucrative hemp industry.

For more information, visit the company’s website at www.EVIOLabs.com
The QualityStocks Daily Newsletter http://Newsletter.QualityStocks.net

The QualityStocks Daily Blogs http://Blog.QualityStocks.net

Please read FULL Compensation Disclosures and other disclaimers at http://www.qualitystocks.net/disclaimer.php
QualityStocks
Site Admin
 
Posts: 1506
Joined: Mon May 21, 2007 7:58 pm
Location: Scottsdale, AZ

Re: EVIO, Inc. (EVIO)

Postby QualityStocks » Tue Oct 31, 2017 4:45 pm

NetworkNewsBreaks – EVIO, Inc. (EVIO) Expands Testing Capabilities at Yuba City Laboratory

EVIO, Inc. (OTCQB: EVIO), a leading provider of cannabis analytical testing services, this morning announced that it has expanded testing capabilities at its Yuba City laboratory in Northern California. The expansion comes in anticipation of California’s new 2018 testing rules and includes a full suite of testing services, such as pesticide, microbiological and expanded cannabinoid potency testing. “We are getting feedback directly from clients on the ground in California that is similar to what we experienced in Oregon back in 2015 when we opened our first lab in Oregon a full year before the official rollout of their testing requirements,” William Waldrop, CEO of EVIO, stated in the news release. “We anticipate California will play out in a very similar fashion, albeit on a much grander and profitable scale, as California is projected to be largest retail cannabis marketplace on earth. California’s cannabis market is forecasted to have at least 10 times market opportunity for analytical testing revenues over Oregon where EVIO currently tests close to 25% of all cannabis products on the shelves for sale in the state.”
The QualityStocks Daily Newsletter http://Newsletter.QualityStocks.net

The QualityStocks Daily Blogs http://Blog.QualityStocks.net

Please read FULL Compensation Disclosures and other disclaimers at http://www.qualitystocks.net/disclaimer.php
QualityStocks
Site Admin
 
Posts: 1506
Joined: Mon May 21, 2007 7:58 pm
Location: Scottsdale, AZ

Re: EVIO, Inc. (EVIO)

Postby QualityStocks » Fri Nov 10, 2017 7:03 pm

NetworkNewsBreaks – EVIO, Inc. (EVIO) Engages Macdonald Tuskey for Potential Entry into Canadian Capital Markets

Leading provider of cannabis analytical testing services EVIO, Inc. (OTCQB: EVIO) recently engaged the Macdonald Tuskey law firm regarding its entry into the Canadian capital markets. The law firm has been engaged to assist the company in navigating the potential listing opportunities, related requirements and compliance in Canada. EVIO’s objective of listing its stock on the Canadian capital market could result in increased liquidity and an improved ability to raise capital for the company. A new listing may also increase EVIO’s visibility in the booming Canadian cannabis market.
The QualityStocks Daily Newsletter http://Newsletter.QualityStocks.net

The QualityStocks Daily Blogs http://Blog.QualityStocks.net

Please read FULL Compensation Disclosures and other disclaimers at http://www.qualitystocks.net/disclaimer.php
QualityStocks
Site Admin
 
Posts: 1506
Joined: Mon May 21, 2007 7:58 pm
Location: Scottsdale, AZ

Re: EVIO, Inc. (EVIO)

Postby QualityStocks » Tue Nov 21, 2017 6:02 pm

NetworkNewsBreaks – EVIO, Inc. (EVIO) Anticipates Growth Through Imminent Regulation Change in California

Leading provider of cannabis analytical testing services EVIO, Inc. (OTCQB: EVIO) is anticipating the new testing rules for cannabis in California as a potential opportunity to profit. EVIO provides the regulated cannabis industry with accredited analytical testing services to ensure compliancy. An article discussing this reads: “The new more stringent tests are important because EVIO sees California as not only a vibrant opportunity, but eventually the biggest cannabis marketplace in the world. Regimented regulatory oversight is to be expected, including lab testing, the company said. According to the San Diego Union-Tribune (http://nnw.fm/6cpwY), California’s cannabis industry could be worth from $4-$7 billion.”
The QualityStocks Daily Newsletter http://Newsletter.QualityStocks.net

The QualityStocks Daily Blogs http://Blog.QualityStocks.net

Please read FULL Compensation Disclosures and other disclaimers at http://www.qualitystocks.net/disclaimer.php
QualityStocks
Site Admin
 
Posts: 1506
Joined: Mon May 21, 2007 7:58 pm
Location: Scottsdale, AZ

Re: EVIO, Inc. (EVIO)

Postby QualityStocks » Wed Nov 22, 2017 7:13 pm

NetworkNewsBreaks – EVIO, Inc. (EVIO) Obtains Expanded Accreditation to Conduct Pesticide, Residual Solvent Tests

EVIO, Inc. (OTCQB: EVIO), a national leader in providing accredited analytical testing, scientific research and advisory services to the regulated cannabis industry, today announced that it has been granted an expansion to its accreditations from the Oregon Environmental Laboratory Accreditation Program (“ORELAP”), a division of the Oregon Health Authority. The newly expanded accreditations enable EVIO Labs to offer full-scope pesticide testing at its Medford location. Additionally, EVIO received accreditation to test for residual solvent residues at its Portland location. "Bringing pesticide testing fully in-house and expanding our capability with residual solvent analysis will also allow us to substantially increase our market opportunity and simultaneously become an even more formidable competitor statewide," EVIO CEO William Waldrop stated in the news release.
The QualityStocks Daily Newsletter http://Newsletter.QualityStocks.net

The QualityStocks Daily Blogs http://Blog.QualityStocks.net

Please read FULL Compensation Disclosures and other disclaimers at http://www.qualitystocks.net/disclaimer.php
QualityStocks
Site Admin
 
Posts: 1506
Joined: Mon May 21, 2007 7:58 pm
Location: Scottsdale, AZ

Re: EVIO, Inc. (EVIO)

Postby QualityStocks » Mon Dec 11, 2017 6:13 pm

NetworkNewsBreaks – EVIO, Inc. (EVIO) Signs Non-Binding LOI to Acquire Licensed Cannabis Laboratory in Berkeley, CA

EVIO (OTCQB: EVIO) this morning announced that it has signed a non-binding Letter of Intent (“LOI”) to acquire 60% of C3 Labs, LLC. C3 Labs is located in Berkeley, CA, which accelerates the company’s intent to expand into Northern California prior to the anticipated increase in demand for analytical testing services. Subject to customary closing conditions, the transaction is expected to close in the first quarter of 2018. “C3 Labs been serving the cannabis industry for years, providing product formulation, research and development services that aligns with EVIO’s longer term strategy to expand our scope of services. We are working to close this transaction in an expeditious manner to begin serving the California market by first quarter 2018,” EVIO CEO William Waldrop stated in the news release.
The QualityStocks Daily Newsletter http://Newsletter.QualityStocks.net

The QualityStocks Daily Blogs http://Blog.QualityStocks.net

Please read FULL Compensation Disclosures and other disclaimers at http://www.qualitystocks.net/disclaimer.php
QualityStocks
Site Admin
 
Posts: 1506
Joined: Mon May 21, 2007 7:58 pm
Location: Scottsdale, AZ

Re: EVIO, Inc. (EVIO)

Postby QualityStocks » Tue Dec 26, 2017 6:06 pm

NetworkNewsBreaks – EVIO, Inc. (EVIO) Licensee Attains ISO 17025 Accreditation

EVIO, Inc. (OTCQB: EVIO), a life sciences company and leading provider of quality control testing and advisory services to the regulated cannabis industry, this morning announced that its Colorado licensee, PhytaTech CO, has attained ISO 17025 accreditation, which requires consistent production of precise and accurate tests and implementation of a rigorous quality management system. Per the update, ISO 17025 is the highest recognized quality standard for calibration and testing laboratories. “As one of only a few Colorado Cannabis Testing labs that have achieved ISO 17025 accreditation, PhytaTech is at the leading edge of testing in the state,” Stephen Goldman, PhytaTech’s laboratory director, stated in the news release. “This achievement speaks to our commitment to the highest standards at every step of the testing process.” EVIO is currently in the process of obtaining ISO 17025 accreditation for its labs in Florida, Massachusetts and California, according to CEO William Waldrop.
The QualityStocks Daily Newsletter http://Newsletter.QualityStocks.net

The QualityStocks Daily Blogs http://Blog.QualityStocks.net

Please read FULL Compensation Disclosures and other disclaimers at http://www.qualitystocks.net/disclaimer.php
QualityStocks
Site Admin
 
Posts: 1506
Joined: Mon May 21, 2007 7:58 pm
Location: Scottsdale, AZ

Re: EVIO, Inc. (EVIO)

Postby QualityStocks » Tue Jan 02, 2018 6:37 pm

NetworkNewsBreaks – EVIO, Inc. (EVIO) Acquires Stake in C3 Labs, LLC

EVIO, Inc. (OTCQB: EVIO), a life sciences company and leading provider of quality control testing and advisory services to the regulated cannabis industry, this morning announced that it has completed the acquisition of 60 percent of C3 Labs, LLC, one of the nation’s first cannabis-focused contract research organizations. EVIO also maintains the option to purchase the remaining ownership stake in C3 Labs for an initial period of three years, subject to C3 member approval. “The addition of C3 Labs to the EVIO network is a tremendous milestone for EVIO Inc.,” William Waldrop, CEO of EVIO, stated in the news release. “C3 Labs generated over $1M in consulting revenues during the last two years, EVIO plans to continue offering these services along with traditional compliance testing. The 8,000 square foot facility is already outfitted with the latest analytical testing equipment, and will become our Northern California hub laboratory… Demand for testing services is expected to increase significantly as the state rolls out its adult-use marijuana market.”
The QualityStocks Daily Newsletter http://Newsletter.QualityStocks.net

The QualityStocks Daily Blogs http://Blog.QualityStocks.net

Please read FULL Compensation Disclosures and other disclaimers at http://www.qualitystocks.net/disclaimer.php
QualityStocks
Site Admin
 
Posts: 1506
Joined: Mon May 21, 2007 7:58 pm
Location: Scottsdale, AZ

Re: EVIO, Inc. (EVIO)

Postby QualityStocks » Wed Jan 03, 2018 6:52 pm

NetworkNewsBreaks – EVIO, Inc. (EVIO) Appoints New President

EVIO, Inc. (OTCQB: EVIO), a life sciences company and leading provider of quality control testing and advisory services to the regulated cannabis industry, this morning announced the appointment of Al Lustig as its new president. Reporting directly to EVIO CEO William Waldrop, Lustig’s primary responsibility in this position will be to drive the company’s growth in both new and existing markets by developing and executing national and international sales and operational strategies. “As we embark upon our next stage of rapid growth, Al’s history of recognized success in corporate growth and sales leadership at Pfizer, one of the world’s largest bio-pharmaceutical companies, makes him the perfect fit to help lead EVIO into 2018 and beyond,” Waldrop stated in the news release. “We look forward to leveraging Al’s leadership and expertise from the pharmaceutical sector. Current EVIO President and Chief Operating Officer Lori Glauser has resigned from her position as President to make room for Al in the Senior Leadership team. Ms. Glauser will remain with the company as Chief Operating Officer, leading both our advisory services division and laboratory expansion.”
The QualityStocks Daily Newsletter http://Newsletter.QualityStocks.net

The QualityStocks Daily Blogs http://Blog.QualityStocks.net

Please read FULL Compensation Disclosures and other disclaimers at http://www.qualitystocks.net/disclaimer.php
QualityStocks
Site Admin
 
Posts: 1506
Joined: Mon May 21, 2007 7:58 pm
Location: Scottsdale, AZ

Re: EVIO, Inc. (EVIO)

Postby QualityStocks » Thu Jan 18, 2018 7:58 pm

NetworkNewsBreaks – EVIO, Inc. (EVIO) Highlights Financial Results for Year Ended September 30, 2017

EVIO, Inc. (OTCQB: EVIO), a life sciences company and leading provider of quality control testing and advisory services to the regulated cannabis industry, this morning announced its financial and operating results for the fiscal year ended September 30, 2017. The company’s revenue for the 12-month period was roughly $3 million, marking a year-over-year increase of 438 percent. Per the update, the majority of this growth came from increased testing revenue, which was up 782 percent over the previous year. “2017 has been a pivotal year for EVIO, especially as we continued to scale the company to meet the industry’s increased needs for mandatory testing,” William Waldrop, chairman and chief executive officer of EVIO, stated in the news release. “We are extremely pleased with our results for the fiscal year 2017.”
The QualityStocks Daily Newsletter http://Newsletter.QualityStocks.net

The QualityStocks Daily Blogs http://Blog.QualityStocks.net

Please read FULL Compensation Disclosures and other disclaimers at http://www.qualitystocks.net/disclaimer.php
QualityStocks
Site Admin
 
Posts: 1506
Joined: Mon May 21, 2007 7:58 pm
Location: Scottsdale, AZ

Re: EVIO, Inc. (EVIO)

Postby QualityStocks » Mon Jan 29, 2018 5:29 pm

NetworkNewsBreaks – EVIO, Inc. (EVIO) Appoints New Vice President of Operations

EVIO, Inc. (OTCQB: EVIO), a life sciences company and leading provider of quality control testing and advisory services to the regulated cannabis industry, this morning announced its appointment of Ron Russak as its new vice president of operations. Per the update, Russak joins EVIO from a 17-year career at Quest Diagnostics where, as regional director, he had operational responsibility for 529 patient service centers and 228 inter-office phlebotomy sites throughout the western United States. “After an exhaustive search, we knew immediately that Ron was the right fit for EVIO,” Lori Glauser, co-founder and COO of EVIO, stated in the news release. “His experience with Quest, a Fortune 500 provider of diagnostic services with a global network of labs and service centers, aligns seamlessly with our desire to rapidly scale up our laboratory operations.” In his new role, Russak will be responsible for providing operational direction and leadership for EVIO’s portfolio of labs and will play a role in driving the company’s profitability and growth by scaling existing and new laboratory operations.
The QualityStocks Daily Newsletter http://Newsletter.QualityStocks.net

The QualityStocks Daily Blogs http://Blog.QualityStocks.net

Please read FULL Compensation Disclosures and other disclaimers at http://www.qualitystocks.net/disclaimer.php
QualityStocks
Site Admin
 
Posts: 1506
Joined: Mon May 21, 2007 7:58 pm
Location: Scottsdale, AZ

Re: EVIO, Inc. (EVIO)

Postby QualityStocks » Thu Feb 01, 2018 5:16 pm

NetworkNewsBreaks – EVIO, Inc. (EVIO) Secures Over $5.9M in New Financing to Fund Expansion

EVIO (OTCQB: EVIO), a life sciences company and leading provider of quality control testing and advisory services to the regulated cannabis industry, this morning said it has successfully closed its latest round of financing totaling $5,973,000. The capital raise exceeded EVIO management’s original goal of only raising $3 million to finance the company’s expansion in California. The company intends to use the additional funds toward increasing its infrastructure through California and to fuel an expansion into multiple states throughout the US, rapidly increasing its national footprint.
The QualityStocks Daily Newsletter http://Newsletter.QualityStocks.net

The QualityStocks Daily Blogs http://Blog.QualityStocks.net

Please read FULL Compensation Disclosures and other disclaimers at http://www.qualitystocks.net/disclaimer.php
QualityStocks
Site Admin
 
Posts: 1506
Joined: Mon May 21, 2007 7:58 pm
Location: Scottsdale, AZ

Re: EVIO, Inc. (EVIO)

Postby QualityStocks » Thu Feb 01, 2018 5:45 pm

EVIO, Inc. (EVIO) Provides a Critical Service to the Regulated Cannabis Industry

- EVIO is a leading accredited provider of analytical services to the regulated cannabis industry
- The company currently operates nine laboratories in five states
- EVIO is on track to open 18 labs around the U.S. by the end of 2018

EVIO, Inc. (OTCQB: EVIO) provides clients across the United States with consistent, high-quality cannabis analytical services. Backed by a stringent quality control assurance program, the company’s laboratory division, EVIO Labs, is the leading provider of accredited analytical testing, scientific research and advisory services to enterprises in the U.S. regulated cannabis industry. The ancillary services provided by EVIO Labs are state-mandated, requiring the company to ensure the safety and quality of cannabis supplied throughout the nation.

Over the past two years, EVIO Labs has performed more than 50,000 tests, mostly consisting of analysis and testing of cannabis and industrial hemp-based flower, extracts and infused products. The company has grown from one laboratory in Oregon to nine labs in five states, including California, Colorado, Florida, Massachusetts and Oregon. EVIO Labs is on track to open 18 laboratory facilities at other locations around the United States by the end of 2018. Apart from its analytical services, the company provides advisory services to help cannabis producers and retailers enhance production processes, meet quality goals and achieve regulatory compliance.

EVIO Labs has built up its leading position in cannabis biotechnology by leveraging the extensive experience of its scientists and management team. The company’s laboratories specialize in performing analysis for cannabinoids, terpenes and pesticide residues. They also conduct tests for moisture content, as well as the detection of heavy metals and harmful residual solvents from the cannabis extraction process. EVIO Labs has extensive experience in product research and development, analytical chemistry techniques and the cultivation and production of medical cannabis. The company’s management team has a solid track record in designing and rolling out successful business ventures, ensuring conformance to regulatory and compliance standards.

On December 26, 2017, EVIO announced that its Colorado licensee, PhytaTech CO, had attained ISO 17025 accreditation, the highest recognized quality standard for calibration and testing laboratories. Adherence to this standard requires consistent precision and accuracy of testing, and the implementation of a rigorous quality management system. In early January 2018, EVIO acquired a 60 percent stake in C3 Labs, LLC, located in Berkley, California, with an option to purchase the remaining shareholding over the next three years.

In releasing this news, EVIO’s CEO, William Waldrop, stated, “C3 Labs generated over $1M in consulting revenues during the last two years. EVIO plans to continue offering these services along with traditional compliance testing. The 8,000 square foot facility is already outfitted with the latest analytical testing equipment, and will become our Northern California hub laboratory… Demand for testing services is expected to increase significantly as the state rolls out its adult-use marijuana market.”

On January 3, 2018, EVIO announced the appointment of Al Lustig as its new president, reporting to Waldrop. Lustig has a track record of success in sales management and corporate growth at Pfizer, one of the world’s largest biopharmaceutical companies. He will be tasked with driving company growth, as well as developing and executing both national and international sales, and operational strategies. EVIO also appointed a new vice president of operations, Ron Russak, on January 29, 2018. Russak had regional operational responsibility, during a 17-year career with Quest Diagnostics, for 529 patient service centers and 228 inter-office phlebotomy sites in the U.S. He will play a major role in driving the expansion of the company’s laboratory operations.

With its established reputation for accredited analytical, research and development, and advisory services, EVIO is poised to expand its operations across North America. Recent key appointments have strengthened the management team to ensure that the company is well positioned to capitalize on the rapidly growing cannabis industry.

For more information, visit the company’s website at www.EVIOLabs.com
The QualityStocks Daily Newsletter http://Newsletter.QualityStocks.net

The QualityStocks Daily Blogs http://Blog.QualityStocks.net

Please read FULL Compensation Disclosures and other disclaimers at http://www.qualitystocks.net/disclaimer.php
QualityStocks
Site Admin
 
Posts: 1506
Joined: Mon May 21, 2007 7:58 pm
Location: Scottsdale, AZ

Re: EVIO, Inc. (EVIO)

Postby QualityStocks » Tue Feb 06, 2018 5:30 pm

EVIO, Inc. (EVIO) is Exceeding Expectations

- Investor interest nearly doubles size of placement
- Company’s 2017 revenues soared 438 percent year-over-year
- On pace to double number of testing facilities this year

The regulatory uncertainties surrounding cannabis will have little impact on the long-term growth of the industry. There’s overwhelming scientific evidence validating the medical efficacy of certain cannabinoids and, like all medications, cannabinoids require quality control assurances for potency and purity. Also, much like prohibition, it’s realistic to expect parochial federal regulators to ultimately succumb to the will of the majority and relax any uncertainties around recreational cannabis use. Again, the end product must be tested and screened for potency and any potentially harmful byproducts.

EVIO, Inc. (OTCQB: EVIO) is the established national leader in such testing and verification, providing accredited cannabis testing, as well as high-quality analytical and consulting services for agricultural and biomedical industries in the United States. Operating coast-to-coast, the company’s EVIO Labs division provides state-mandated ancillary services to ensure both safety and quality of the nation’s cannabis supply. The company provides state-of the-art analytical testing and advisory services, and it performs extensive product research in its accredited laboratory testing facilities.

In a recent vote of confidence for EVIO, as well as in the long-term viability and opportunities in the cannabis industry, EVIO just closed a $5,973,000 private placement. The initial target of $3 million was nearly doubled due to investor interest in EVIO’s uniquely scalable business model and scientific expertise in the cannabis testing space (http://nnw.fm/1GdJk).

Market savants fully understand that fresh capital seldom flows to dead-end deals, and doubling the raise is a significant signal of potential success. The best-efforts offering was completed on January 30 through lead agent and bookrunner Dominick Capital Corporation of Toronto, Canada.

As further evidence of EVIO’s growth curve, the company reported a 438 percent revenue increase on a year-over-year basis in its fiscal year ended September 30, 2017 (http://nnw.fm/DY4mD). The vast majority of this growth came from increased testing revenue, which was up 782 percent, while consulting services increased by 27 percent.

EVIO has grown from one laboratory in Oregon to nine fully operational laboratories in California, Colorado, Florida, Massachusetts and Oregon, and it intends to open 18 laboratory facilities at other locations around the United States by the end of 2018.

For more information, visit the company’s website at www.EVIOLabs.com
The QualityStocks Daily Newsletter http://Newsletter.QualityStocks.net

The QualityStocks Daily Blogs http://Blog.QualityStocks.net

Please read FULL Compensation Disclosures and other disclaimers at http://www.qualitystocks.net/disclaimer.php
QualityStocks
Site Admin
 
Posts: 1506
Joined: Mon May 21, 2007 7:58 pm
Location: Scottsdale, AZ

Next

Return to QualityStocks Featured Companies

Who is online

Users browsing this forum: No registered users and 3 guests

cron